Drug Profile
BL 2401
Alternative Names: BL-2401Latest Information Update: 14 Jun 2000
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical
- Class Analgesics; Antidepressants
- Mechanism of Action Neprilysin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 14 Jun 2000 Discontinued-Preclinical for Pain in Japan (PO)
- 31 Mar 1998 Preclinical development for Pain in Japan (PO)